DEXCOM INC
Company Stats
- Market Cap
- $32.6B
- as of Sep 30, 2026
- Shares Outstanding
- 377.4M
- Free Float
- 99.5%
Income Statement
- Revenue
- $4.7B
- Operating Income
- $911.8M
- Net Income
- $836.3M
- EBITDA
- $1.2B
- Revenue Growth, 3Y
- 17.0%
- FCF Margin, 3Y Avg
- 17.6%
- FCF Margin, Worst Year
- 14.1%
Cash Flow
- Free Cash Flow
- $1.1B
- FCF Yield
- 3.3%
- Owner FCF Yield
- 2.8%
Balance Sheet
- Cash & Equivalents
- $917.7M
Returns & Capital
- Share Repurchases
- $500.0M
- Buyback Yield, 3Y Avg
- 2.0%
- SBC, 3Y Avg
- $160.3M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $4.7B | $1.1B | 23.1% |
| FY2024 | $4.0B | $630.7M | 15.6% |
| FY2023 | $3.6B | $511.9M | 14.1% |
| FY2022 | $2.9B | $304.7M | 10.5% |
| FY2021 | $2.4B | $53.3M | 2.2% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 27, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back